Mike Stratton
Direttore/Membro del Consiglio presso Wellcome Trust Sanger Institute
Profilo
Mike Stratton is the founder of Quotient Therapeutics Ltd., which was founded in 2022.
He is currently the Director at Wellcome Trust Sanger Institute.
Posizioni attive di Mike Stratton
| Società | Posizione | Inizio |
|---|---|---|
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mike Stratton
| Società | Posizione | Fine |
|---|
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Mike Stratton